Introduction
============

One of the cornerstone points in coronary artery diseases (CADs) diagnosis improving remarkably is coronary angiography (CAG). Since the first execution of this method in 1929, this procedure has become one of the most common modalities done to either diagnose or treat all related CADs. Despite the old method of transfemoral approach (TFA) remaining the standard therapeutic modality, which was associated with higher rates of complications, other novel options have been introduced based on raised equipment technology.[@b1-ARYA-16-033] The transradial approach (TRA) for CAG first announced in 1989 was the initiation of a new era in this regard.[@b2-ARYA-16-033]

Lower complication and mortality rates plus faster discharge period and patient convenience and early ambulation, as well as declining management costs, were some potential advantages of the modality as mentioned above, making this approach to be considered as an appropriate surrogate to TFA.[@b3-ARYA-16-033]-[@b8-ARYA-16-033] However, smaller radial artery (RA) diameter, anatomical abnormalities, arterial spasms, or needing the desired artery for coronary artery bypass graft (CABG) surgery were reported to be some difficulties attributable to TRA.[@b9-ARYA-16-033]-[@b11-ARYA-16-033] Another option first introduced by Terashima et al. in 2001 providing a better alternative modality especially in terms of TRA failure, was CAG with a transulnar approach (TUA).[@b12-ARYA-16-033] Although most studies revealed a similar efficacy of TUA in comparison to TRA as well as easier approach way plus less anatomical variations as well as arterial vasospasm rates, Roghani-Dehkordi et al.[@b13-ARYA-16-033] Dahal et al.[@b14-ARYA-16-033] revealed that TUA was associated with higher rates of puncture attempts and cross-over to other current diagnosis and therapeutic modalities. Also, the deep location of the ulnar artery (UA) near the ulnar nerve might play an essential role in incidence of complications.[@b15-ARYA-16-033] By the way, TUA safety in terms of ipsilateral radial artery occlusion (RAO)5 is less frequently investigated in literature with findings from as mild as minor hematoma to as significant as UA obstruction.[@b16-ARYA-16-033],[@b17-ARYA-16-033] On the other hand, this approach has been proved to be efficacious even in terms of visceral diagnostic and therapeutic angiographic procedures.[@b18-ARYA-16-033]

In this article, we aimed to evaluate the feasibility and occurrence of probable complications with TUA in patients with ipsilateral RAO.

Materials and Methods
=====================

This prospective double-center study was designed to be performed in two governmental heart centers located in Isfahan City, Iran (Shahid Chamran and Khorshid Hospitals). Any individual more than 18 years old eligible for CAG or angioplasty without right RA pulsation due to previous coronary interventions with TRA, prior history of arterial surgery for arteriovenous fistula (AVF) or graft procedures, and vascular anomalies or severe arterial spasm was recruited in our study from July 2017 to November 2018. Presence of carpal tunnel, Guyon's canal or hypothenar hammer syndrome (HHS), elective TFA, motor or sensory deficits along the median or ulnar nerve route, medial wrist bone fracture, severe hand deformity or chronic tenosynovitis, as well as osteomyelitis (OM) was defined as exclusion criteria. Before the initiation of the procedure, all research aims were explained to each individual and the coordinator entirely answered probable questions. After that, each participant was asked to sign an informed consent form. After collection of all appropriate information, 70 individuals met our predefined inclusion criteria. The Ethics Committee of Isfahan University of Medical Sciences approved this study (No. 398101).

After proper preparation of patients for the procedure, approximately 2 cm above ulnar hand bone was marked, and 1.5 ml of lidocaine (2%) was injected subcutaneously. Afterward, 5-6 French hydrophilic sheath (Merit Medical, Utah, USA) was used concurrently with a spasmolytic cocktail consisting of 2.5 mg of verapamil plus 250 µg of nitroglycerine as well as 2500 international unit (IU) of unfractionated heparin (UFH) ([Figure 1](#f1-ARYA-16-033){ref-type="fig"}). In terms of CAG, 6 inches right and left Judkins (Medtronic, Minneapolis, MN, USA) or Tiger (Terumo Interventional Systems, Somerset, NJ, USA) catheters were used. In need of coronary angioplasty, 6 inches right/left Judkins and extra backup catheters were utilized. After complementation of process, hemostasis was done with right wrist hyperextension and local pressure for 5-10 minutes, followed by ulnar TR band compression afterward.

We used each participant's medical form to gather information about age, gender, body mass index (BMI), smoking status, and family history of CADs as well as past medical history data including hypertension (HTN), diabetes mellitus (DM), hyperlipidemia, and myocardial infarction (MI).

Access time was defined from the initiation of lidocaine injection to the time of sheath insertion. Any correct UA cannulation was considered a successful procedure. Moreover, fluoroscopy and procedure time, as well as contrast volume consumption, were assessed during the procedure implementation. Presence or absence of complications including pain, ulnar nerve palsy, infection, hematoma \[≤ 5 cm, ≤ 10 cm, and \> 10 cm in diameter just below the elbow for grade I, II, and III, respectively, expanding hematoma above the elbow (grade IV) and any place with limb ischemia threads (grade V)\], life-threatening hand ischemia, AVF, pseudoaneurysm formation, UA narrowing or occlusion as well as any adverse events requiring vascular surgery plus major adverse cardiac events (MACE) including death, MI, and stroke was assessed at discharge date and follow-up duration after one month as primary endpoints.

Categorical and continuous variables were reported as frequency (percentage) and mean ± standard deviation (SD), respectively. All analyses were done with the SPSS software (version 20, IBM Corporation, Armonk, NY, USA).

Results
=======

The mean age of patients who underwent TUA was 68.2 ± 12.8 years. Male participants were the dominant contributor to our study sample \[n = 41, (58.5%)\]. The most prevalent metabolic abnormality found in the study population was hyperlipidemia (54.2%), followed by DM (44.2%) and HTN (40.0%) ([Table 1](#t1-ARYA-16-033){ref-type="table"}).

The detailed information of the TUA procedure is represented in [table 2](#t2-ARYA-16-033){ref-type="table"}. On 69 patients, TUA was done successfully, and our success rate was estimated to be 98.6%. We had to cross over to TFA in just one person due to the tortuosity of the UA. In addition to CAG done for all participants, 26 of them (37.1%) underwent coronary angioplasty. The mean access time was 9.7 ± 2.3 minutes. Angiography and angioplasty fluoroscopy duration was 5.3 ± 1.4 minutes and 11.2 ± 2.2 minutes, respectively.

Contrast volume used in angioplasty and angiography procedures was 253 ± 32 and 144 ± 24 ml, respectively. Moreover, the time needed for trans-ulnar angioplasty and the diagnostic procedure was 34.8 ± 7.9 and 18.2 ± 4.6 minutes, respectively. Data on our major endpoints which were defined as complication occurrence rates after the procedure and one month afterward are provided in [table 3](#t3-ARYA-16-033){ref-type="table"}.

Pain controlled by pain-relieving agents had been reported in 8 individuals (11.4%). 5.7% of cases experienced minor hematoma (grade I) which was managed conservatively. No other adverse outcomes in terms of life-threatening hand ischemia, infection, ulnar nerve palsy, AVF, and pseudoaneurysm formation, as well as complications needing immediate vascular surgery, had been reported. One individual who underwent percutaneous coronary intervention (PCI) experienced MACE including transient ischemic attack (TIA), which relieved entirely within 24 hours.

During one month after intervention, asymptomatic ulnar artery occlusion (UAO) and severe narrowing were reported in 2 patients (2.8%) and 1 patient (1.4%), respectively, that was confirmed by duplex ultrasonography. None of them had clinical signs and symptoms of hand ischemia during the follow-up period. A brief explanation of the study design and complication incidence was illustrated in [figure 2](#f2-ARYA-16-033){ref-type="fig"}.

Discussion
==========

We constructed the current study to evaluate the feasibility and occurrence of complications in patients with ipsilateral RAO who underwent TUA. Our findings revealed that except for a few cases experiencing minor hematoma, controllable pain, and MACE managed conservatively as well as asymptomatic UAO and severe narrowing in the next month of follow-up duration in just 3 cases, we had a 98.6% success rate and no other previous pre-defined complications occurred at all. While TRA has been classified as a usual coronary diagnostic and therapeutic modality in most centers, low incidence of complications as well as high successful rates could categorize TUA as an appropriate alternative procedure compared to TRA, especially in individuals who did not have a patent RA. Concerning this point that TUA in the presence of RAO has been less studied in the literature, few studies were performed with similar findings. Hsueh et al. retrospectively investigated 87 patients who underwent TUA due to the inability to perform ipsilateral TRA because of multiple reasons like arteriovenous anastomosis for hemodialysis, RA harvest for CABG, weak pulse, and failed puncture attempts to evaluate possible complications incidence. The mean access and total procedural times were 5.0 ± 5.7 minutes and 72.6 ± 43.6 minutes, respectively. Their success rate of cannulation was reported to be 98.9%. Follow-up duration both during hospitalization and 32.2 ± 24.0 months afterward revealed that in spite of hematoma (2.3%), repeated revascularization (1.1%), and acute or chronic thrombosis (1.1%), no other adverse outcomes including UA obstruction, pseudoaneurysm or AVF formation, neurologic problems, hand ischemia, any complications requiring vascular surgery or blood transfusion and stroke, as well as death, happened in any participants.[@b15-ARYA-16-033] Likewise, 476 individuals who underwent TUA were studied from March 2011 to February 2013 in Kedev et al.'s study. Their further survey showed that 240 of them also had ipsilateral RAO. Data analysis announced that during a follow-up of one month, no major vascular adverse outcomes and UAO were reported. By the way, 7% of participants experienced a clinical spasm of UA and the prevalence of grades 1, 2, 3, and 4 of hematoma was 3.7%, 2.0%, 1.6%, and 0.4%, respectively.[@b19-ARYA-16-033] Also, 17 patients with a mean age of 77 years requiring CAG or intervention underwent TUA in the presence of ipsilateral RAO and were followed for 30 days for assessment of the probable incidence of post-procedural complications. In addition to a 100% successful procedure rate and no ulnar nerve injury or hand ischemia occurrence, both hematoma and UA spasm were observed in just two cases.

Moreover, follow-up investigation failed to report UA obstruction on days 1, 7, or 30 after initiation of the procedure.[@b20-ARYA-16-033] Even more, this desirable safety index has been reported in TUA for non-coronary diagnostic and therapeutic interventions. Zybulewski et al. recruited 14 participants with a mean age of 60 years for visceral intervention with simultaneous contraindication for TRA. They reported a successful cannulated rate of 94.1% (16 successful attempts out of 17 ones) and did not report any major adverse events including access site bleeding or hemorrhagic complications. Only two individuals experienced minor hematoma in the access site.[@b18-ARYA-16-033]

Although it might have appeared that TUA in the presence of ipsilateral RAO could cause life-threatening hand ischemia and might be considered a contraindication in performing this modality, anterior interosseous artery would play a pivotal role in preventing these adverse outcomes.[@b15-ARYA-16-033],[@b17-ARYA-16-033] An experienced interventional cardiologist performed all procedures and clinical follow-up visits in this regard. However, some limitations could be considered for our study including non-randomized study design plus a quite small sample size. Moreover, a short pre-defined follow-up duration disabled us to perform a thorough assessment of probable complications. Finally, the inability to compare our outcomes with individuals who underwent TUA without RAO for better deduction might affect our results.

Conclusion
==========

This study suggested that TUA could appropriately be considered as an alternative modality in patients suffering from ipsilateral RAO due to its high safety and feasibility as well as low complication rates.
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###### 

Basic characteristics of patients undergoing a transulnar approach (TUA)

  Variables                         TUA           
  --------------------------------- ------------- -----------
  Age (year)                        68.2 ± 12.8   
  BMI (kg/m^2^)                     26.4 ± 3.8    
  Male gender                       41 (58.5)     
  Current smoker                    24 (34.2)     
  HTN                               28 (40.0)     
  DM                                31 (44.2)     
  Hyperlipidemia                    38 (54.2)     
  Previous MI                       12 (17.1)     
  Positive family history of CADs   18 (25.7)     
  Procedure                         CAG           44 (62.9)
                                    PCI           26 (37.1)

Data are presented as frequency (percentage) and mean ± standard deviation (SD)

TUA: Transulnar approach; BMI: Body mass index; HTN: Hypertension; DM: Diabetes mellitus; MI: Myocardial infarction; CAD: Coronary artery disease; CAG: Coronary angiography; PCI: Percutaneous coronary intervention

###### 

Transulnar approach (TUA) procedural characteristics in study participants

  Procedure characteristics                TUA
  --------------------------- ------------ --------------
  Cannulation rate            Successful   69 (98.6)
                              Cross-over   1 (1.4)
  Access time (minute)                     9.7 ± 2.3
  Fluoroscopy time (minute)   CAG          5.3 ± 1.4
                              PCI          11.2 ± 2.2
  Contrast volume (ml)        CAG          144.0 ± 24.0
                              PCI          253.0 ± 32.0
  Procedure time (minute)     CAG          18.2 ± 4.6
                              PCI          34.8 ± 7.9

Data are presented as frequency (percentage) and mean ± standard deviation (SD)

TUA: Transulnar approach; CAG: Coronary angiography; PCI: Percutaneous coronary intervention

###### 

Incidence of complications with the transulnar approach (TUA)

  Complications                                      TUA (n = 70)
  ---------------------- --------------------------- --------------
  Hematoma               I                           4 (5.7)
                         II, III, IV, V              0 (0)
  Pain                                               8 (11.4)
  MACE                                               1 (1.4)
  Follow-up assessment   Asymptomatic UAO            2 (2.8)
                         Asymptomatic UA narrowing   1 (1.4)

Data are presented as frequency (percentage)

TUA: Transulnar approach; MACE: Major adverse cardiac events; UAO: Ulnar artery occlusion; UA: Ulnar artery
